Fig. 2From: Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational studyPentraxin-3 level upon admission (baseline) and for the following 3Â days in a septic shock versus nonshock, b amputation versus no amputation, c 180-day mortality and d NSTI versus control. NSTI Necrotizing soft tissue infection, PTX3 Pentraxin-3Back to article page